Abeona Therapeutics: Q1 Earnings Snapshot

Published: 2026-05-13 07:36:08 ET ABEO

Published on 05/13/2026 at 07:36 am EDT

CLEVELAND (AP) — CLEVELAND (AP) — Abeona Therapeutics Inc. (ABEO) on Wednesday reported a loss of $17.1 million in its first quarter.

The Cleveland-based company said it had a loss of 30 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share.

The drug developer posted revenue of $8.7 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $5.6 million.

Abeona Therapeutics shares have increased nearly 8% since the beginning of the year. The stock has climbed slightly more than 1% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABEO at https://www.zacks.com/ap/ABEO

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News